The effects of short-term continuous subcutaneous insulin infusion treatment on fasting glucagon-like peptide-1 concentrations in newly diagnosed type 2 diabetes.

Xiaofei Huang,Sha Li,Mei Yang,Xuquan Fu,Huaqi Li,Tong Yan, Yidong Liu, Lihong Chen, Lingsheng Lan,Libo Li,Xiaowei Zhong

Diabetes Research and Clinical Practice（2018）

引用 3|浏览7

暂无评分

摘要

•Satisfactory glycemic control is obtained by CSII treatment.•β-cell function and GLP-1 concentration improve significantly after treatment.•Overweight and middle-aged patient may get more benefit from the treatment.

查看译文

关键词

Type 2 diabetes mellitus,Beta cell function,Glucagon-like peptide-1,Continuous subcutaneous insulin infusion

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要